Development and In-Vitro Clinical Study of Tinidazole - Chlorhexidine Gluconate ophthalmic suspension for Treatment of Keratitis

Bibliographic Details
Title: Development and In-Vitro Clinical Study of Tinidazole - Chlorhexidine Gluconate ophthalmic suspension for Treatment of Keratitis
Authors: Hiba Muaffak Salmo, Haider Kadum Abbas, Faiz I. Al- Shakarchi, Jamal Abdul-Rahman
Source: Al-Mustansiriyah Journal of Pharmaceutical Sciences, Vol 4, Iss 1 (2007)
Publisher Information: College of Pharmacy / Mustansiriyah University, 2007.
Publication Year: 2007
Collection: LCC:Pharmacy and materia medica
Subject Terms: Pharmacy and materia medica, RS1-441
More Details: A new model aqueous micro fine suspension of tinidazole (TND) was developed on the basis of the combination with chlorhexidine gluconate to be useful in treatment of ungal corneal infection or ulcer (fungal keratitis). In vitro clinical study for TND - chlorhexidine gluconate showed a significant antifungal activity against certain species of fungi isolated from patients with corneal ulcer . Propylene glycol (PG) was chosen because it is known as a good solubilizer , it could be used as a tonicity adjustment agent in appropriate concentration & it is nontoxic . An enhancement in the solubility of TND was achieved also by interaction with a non-ionic surfactant polysorbate 80 (Tween80) and PG. . The models prepared by using PG were showed some practical advantages over the models containing a combination of PG and non –ionic surfactant polysorbate 80 (Tween 80) , by enhancement the in vitro dissolution & releasing of TND suspension . Previous histological studies have shown that these additives used not cause eye irritation. The prepared models showed high physiological tolerance on rabbit eye. Moreover high molecular weight methylcellulose (MC) was effective to create appropriate viscosity that was maintained unchanged after heat sterilization.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1815-0993
2959-183X
Relation: https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/380; https://doaj.org/toc/1815-0993; https://doaj.org/toc/2959-183X
DOI: 10.32947/ajps.v4i1.380
Access URL: https://doaj.org/article/b69422b2c4e44f2c9900f60c1c770b25
Accession Number: edsdoj.b69422b2c4e44f2c9900f60c1c770b25
Database: Directory of Open Access Journals
More Details
ISSN:18150993
2959183X
DOI:10.32947/ajps.v4i1.380
Published in:Al-Mustansiriyah Journal of Pharmaceutical Sciences
Language:English